DJIA 16,597.44 -45.57 -0.27%
NASDAQ 4,815.41 -12.92 -0.27%
S&P 500 1,981.82 -7.05 -0.35%
market minute promo

20.17 -0.17 (-0.84%)

Quote as of


company name or ticker

Recent Quotes

OMED $20.17 -0.84%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $20.13
Previous Close $20.34
Daily Range $19.85 - $20.53
52-Week Range $16.63 - $29.83
Market Cap $606.3M
P/E Ratio -10.71
Dividend (Yield) $0.00 (0.0%)
Volume 36,560
Average Daily Volume 130,075
Current FY EPS -$1.44

Sector

Industry

ONCOMED PHARMACEUTICALS INC (OMED) Description

ONCOMED PHARMACEUTICALS INC Website: http://www.oncomed.com/

News & Commentary

Undervalued Stocks in Biotech Worth Buying

Even though the term "bubble" is being tossed around with regard to biotech stocks, there are still three undervalued stocks in the sector worth buying.

OncoMed Pharmaceuticals' (OMED) CEO Paul Hastings on Q2 2015 Results - Earnings Call Transcript

OncoMed Pharmaceuticals (OMED) Jumps: Stock Rises 5.4% - Tale of the Tape

OncoMed Pharmaceuticals (OMED) Jumps: Stock Rises 5.4% - Tale of the Tape

OncoMed Reports Presentation of Phase 1b Trial for Tarextumab in Small Cell Lung Cancer at ASCO

OncoMed Presents Data From Phase 1b Trial of Demcizumab in Pancreatic Cancer

Insider Trading Alert - OMED, ALQA And SNBC Traded By Insiders

OncoMed Pharmaceuticals' (OMED) CEO Paul Hastings on Q1 2015 Results - Earnings Call Transcript

Health Care Sector Update for 04/22/2015: OMED, HLS, THLD

OncoMed Down on Phase Ib Lung Cancer Study Data - Analyst Blog

In Case You Missed It, This Study May Have Uncovered a New Way to Fight Cancer

Years from now this new study may change the way pharmaceutical companies and physicians fight cancer.

See More OMED News...